Expertise

Bruno Versaevel is Head of the HITS (Healthcare Innovation, Technology & Society) Institute, and Academic Director of the emlyon BioPharma curriculum nested in the Master in Management programme ('Programme Grande Ecole'). In both his teaching and research, he concentrates on industrial organization, with a special interest in the economics of R&D within the biopharmaceutical industry. His research papers have been published in various journals, including the Journal of Health Economics, Drug Discovery Today, and Nature Biotechnology.

Engagements

Media availability
Expert availability
Accredited to Supervise Research
Academic Research

Link

Organizational Affiliations

Head of Institute, HITS - Healthcare Innovation, Technology & Society Institute, emlyon business school

Professor level 1, Department of Quantitative Finance & Economics, emlyon business school

Primary member, QUANT - Quantitative Methods in Business, emlyon business school

Affiliated member, GATE (CNRS)

Education

Economics
2018, Accreditation to supervise research (HDR), Ecole Normale Supérieure de Lyon
Economics
1998, PhD, European University Institute (Italy, Florence) - EUI
Business Economics
1991, Master of Science, University of Manchester (United Kingdom, Manchester)